Dataset Information


Expression profiling of myeloid leukemia cell treated with vibsanine A, PMA and ATRA

ABSTRACT: All-trans retinoic acid (ATRA)-based differentiation therapy has achieved success with the treatment of acute promyelocytic leukemia (APL), a unique subtype of acute myeloid leukemia (AML). However, other subtypes of AML display resistance to ATRA-based treatment. Here, we demonstrate that a novel natural vibsane-type diterpenoid vibsanine A promotes the differentiation of myeloid leukemia cell lines and primary AML blasts. To reveal how vibsanine A function on promoting myeloid leukemia cell differentiation, we analyzed and compared the gene expression profiles in myeloid leukemia HL-60 cells treated with vibsanine A, PMA, and ATRA. HL-60 cells were treated with vibsanine A, PMA and ATRA for 6 hours or longer up to 24 hours. Gene expression profiling was conducted

ORGANISM(S): Homo sapiens  

SUBMITTER: Yu Zuyin   Cong Yuwen 

PROVIDER: E-GEOD-78734 | ArrayExpress | 2016-02-28



Similar Datasets

2004-01-30 | GSE985 | GEO
2004-01-30 | GSE982 | GEO
2012-03-14 | E-GEOD-34672 | ArrayExpress
2012-03-14 | E-GEOD-34725 | ArrayExpress
2015-08-31 | E-GEOD-65297 | ArrayExpress
2007-09-20 | E-GEOD-995 | ArrayExpress
2015-03-31 | E-GEOD-67420 | ArrayExpress
2013-10-09 | E-GEOD-46164 | ArrayExpress
| GSE35159 | GEO
2012-01-18 | E-GEOD-35159 | ArrayExpress